SHERWIN WILLIAMS CO (SHW) Insider Transactions
Explore official ownership filings, with every record linked to its source.
SHW · SHERWIN WILLIAMS CO
How to read this data ↗Recent reported activity
Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.
| Transaction / filed | Reporting owner(s) | Code / security | Quantity | Price as filed | Ownership | Source |
|---|---|---|---|---|---|---|
| 2026-10-20Filed 2026-10-22 | Meisenzahl Benjamin E.Officer · SVP - Finance and CFOFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 These options were granted on October 20, 2026, pursuant to the terms of a stock option agreement under the 2025 Equity and Incentive Compensation Plan. The options vest annually in three substantially equal installments commencing October 20, 2027, subject to vesting conditions. References: F1 | A Award / grantEmployee Stock Option (Right to Buy) · Derivative | 13,805A | 0 | Direct | Form 4 ↗0002103972-26-000007 |
| 2026-10-02Filed 2026-10-06 | Gamgort Robert JamesDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents the number of deferred stock units acquired by the Reporting Person, in an exempt transaction, pursuant to the 2005 Director Deferred Fee Plan ("Deferred Fee Plan"). Each deferred stock unit is the economic equivalent of one share of common stock. The deferred stock units become payable solely in stock, generally following the Reporting Person's separation from service as a Director of the Company. F2 Represents the weighted average share price on the transaction date used to determine the number of deferred stock units to be credited to the Reporting Person's account. F3 These securities consist of deferred stock units, held pursuant to the Deferred Fee Plan, and include deferred stock units acquired pursuant to the dividend reinvestment feature of such Plan. F4 No transaction is being reported on this line. Reported on a previously filed Form 4. F5 These securities consist of 902 restricted stock units ("RSUs") and 173 shares of common stock. Each RSU represents the Reporting Person's right to receive one share of common stock. References: F1, F2, F3 | A Award / grantCommon Stock · Non-derivative | 104.12A | 324.14 | IndirectDeferred Fee Plan | Form 4 ↗0001570836-26-000014 |
| 2026-10-02Filed 2026-10-06 | Williams ThomasDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents the number of deferred stock units acquired by the Reporting Person, in an exempt transaction, pursuant to the 2005 Director Deferred Fee Plan ("Deferred Fee Plan"). Each deferred stock unit is the economic equivalent of one share of common stock. The deferred stock units become payable solely in stock, generally following the Reporting Person's separation from service as a Director of the Company. F2 Represents the weighted average share price on the transaction date used to determine the number of deferred stock units to be credited to the Reporting Person's account. F3 These securities consist of deferred stock units, held pursuant to the Deferred Fee Plan, and include deferred stock units acquired pursuant to the dividend reinvestment feature of such Plan. F4 No transaction is being reported on this line. Reported on a previously filed Form 4. F5 These securities consist of 1,100 restricted stock units ("RSUs") and 1,271 shares of common stock. Each RSU represents the Reporting Person's right to receive one share of common stock. References: F1, F2, F3 | A Award / grantCommon Stock · Non-derivative | 104.12A | 324.14 | IndirectDeferred Fee Plan | Form 4 ↗0001320730-26-000014 |
| 2026-10-02Filed 2026-10-06 | THAMAN MICHAEL HDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents the number of deferred stock units acquired by the Reporting Person, in an exempt transaction, pursuant to the 2005 Director Deferred Fee Plan ("Deferred Fee Plan"). Each deferred stock unit is the economic equivalent of one share of common stock. The deferred stock units become payable solely in stock, generally following the Reporting Person's separation from service as a Director of the Company. F2 Represents the weighted average share price on the transaction date used to determine the number of deferred stock units to be credited to the Reporting Person's account. F3 These securities consist of deferred stock units, held pursuant to the Deferred Fee Plan, and include deferred stock units acquired pursuant to the dividend reinvestment feature of such Plan. F4 No transaction is being reported on this line. Reported on a previously filed Form 4. F5 These securities consist of 1,100 restricted stock units ("RSUs") and 7,011 shares of common stock. Each RSU represents the Reporting Person's right to receive one share of common stock. References: F1, F2, F3 | A Award / grantCommon Stock · Non-derivative | 104.12A | 324.14 | IndirectDeferred Fee Plan | Form 4 ↗0001228309-26-000012 |
| 2026-10-02Filed 2026-10-06 | ANDERSON KERRII BDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents the number of deferred stock units acquired by the Reporting Person, in an exempt transaction, pursuant to the 2005 Director Deferred Fee Plan ("Deferred Fee Plan"). Each deferred stock unit is the economic equivalent of one share of common stock. The deferred stock units become payable solely in stock, generally following the Reporting Person's separation from service as a Director of the Company. F2 Represents the weighted average share price on the transaction date used to determine the number of deferred stock units to be credited to the Reporting Person's account. F3 These securities consist of deferred stock units, held pursuant to the Deferred Fee Plan, and include deferred stock units acquired pursuant to the dividend reinvestment feature of such Plan. F4 No transaction is being reported on this line. Reported on a previously filed Form 4. F5 These securities consist of 1,100 restricted stock units ("RSUs") and 4,719 shares of common stock. Each RSU represents the Reporting Person's right to receive one share of common stock. References: F1, F2, F3 | A Award / grantCommon Stock · Non-derivative | 30.85A | 324.14 | IndirectDeferred Fee Plan | Form 4 ↗0001227159-26-000012 |
| 2026-08-18Filed 2026-08-19 | Binns Justin TOfficer · President, Glob. ArchitecturalFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $353.01 to $352.66 per share. The Reporting Person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 Represents a gift made by the Reporting Person to a charitable donor advised fund. F3 Represents the number of shares of Common Stock attributable to the Reporting Person's participation in The Sherwin-Williams Company 401(k) Plan per the trustee's 6/30/2026 statement. F4 These options were granted on October 18, 2016 and vested in three equal installments on each of the first three anniversaries of the date of grant, subject to vesting conditions. References: F2 | G GiftCommon Stock · Non-derivative | 813D | 0 | Direct | Form 4 ↗0001832316-26-000007 |
| 2026-08-17Filed 2026-08-19 | Binns Justin TOfficer · President, Glob. ArchitecturalFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $353.01 to $352.66 per share. The Reporting Person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 Represents a gift made by the Reporting Person to a charitable donor advised fund. F3 Represents the number of shares of Common Stock attributable to the Reporting Person's participation in The Sherwin-Williams Company 401(k) Plan per the trustee's 6/30/2026 statement. F4 These options were granted on October 18, 2016 and vested in three equal installments on each of the first three anniversaries of the date of grant, subject to vesting conditions. References: F4 | M Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 13,500D | 0 | Direct | Form 4 ↗0001832316-26-000007 |
| 2026-08-17Filed 2026-08-19 | Binns Justin TOfficer · President, Glob. ArchitecturalFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $353.01 to $352.66 per share. The Reporting Person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 Represents a gift made by the Reporting Person to a charitable donor advised fund. F3 Represents the number of shares of Common Stock attributable to the Reporting Person's participation in The Sherwin-Williams Company 401(k) Plan per the trustee's 6/30/2026 statement. F4 These options were granted on October 18, 2016 and vested in three equal installments on each of the first three anniversaries of the date of grant, subject to vesting conditions. References: F1 | S Sale (market/private)Common Stock · Non-derivative | 13,500D | 352.7 | Direct | Form 4 ↗0001832316-26-000007 |
| 2026-08-17Filed 2026-08-19 | Binns Justin TOfficer · President, Glob. ArchitecturalFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $353.01 to $352.66 per share. The Reporting Person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 Represents a gift made by the Reporting Person to a charitable donor advised fund. F3 Represents the number of shares of Common Stock attributable to the Reporting Person's participation in The Sherwin-Williams Company 401(k) Plan per the trustee's 6/30/2026 statement. F4 These options were granted on October 18, 2016 and vested in three equal installments on each of the first three anniversaries of the date of grant, subject to vesting conditions. References: | M Exercise / conversionCommon Stock · Non-derivative | 13,500A | 90.04 | Direct | Form 4 ↗0001832316-26-000007 |
| 2026-08-07Filed 2026-08-11 | Jorgenrud Karl JOfficer · President, Glob. IndustrialFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents the number of shares of Common Stock attributable to the Reporting Person's participation in The Sherwin-Williams Company 401(k) Plan per the trustee's 6/30/2026 statement. F2 These options were granted on October 18, 2017 and vested in three substantially equal installments on each of the first three anniversaries of the date of grant, subject to vesting conditions. References: F2 | M Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 90D | 0 | Direct | Form 4 ↗0001914220-26-000007 |
| 2026-08-07Filed 2026-08-11 | Jorgenrud Karl JOfficer · President, Glob. IndustrialFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents the number of shares of Common Stock attributable to the Reporting Person's participation in The Sherwin-Williams Company 401(k) Plan per the trustee's 6/30/2026 statement. F2 These options were granted on October 18, 2017 and vested in three substantially equal installments on each of the first three anniversaries of the date of grant, subject to vesting conditions. References: | S Sale (market/private)Common Stock · Non-derivative | 7,886D | 368.3 | Direct | Form 4 ↗0001914220-26-000007 |
| 2026-08-07Filed 2026-08-11 | Jorgenrud Karl JOfficer · President, Glob. IndustrialFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents the number of shares of Common Stock attributable to the Reporting Person's participation in The Sherwin-Williams Company 401(k) Plan per the trustee's 6/30/2026 statement. F2 These options were granted on October 18, 2017 and vested in three substantially equal installments on each of the first three anniversaries of the date of grant, subject to vesting conditions. References: | M Exercise / conversionCommon Stock · Non-derivative | 90A | 127.98 | Direct | Form 4 ↗0001914220-26-000007 |
| 2026-07-06Filed 2026-07-08 | Gamgort Robert JamesDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents the number of deferred stock units acquired by the Reporting Person, in an exempt transaction, pursuant to the 2005 Director Deferred Fee Plan ("Deferred Fee Plan"). Each deferred stock unit is the economic equivalent of one share of common stock. The deferred stock units become payable solely in stock, generally following the Reporting Person's separation from service as a Director of the Company. F2 Represents the weighted average share price on the transaction date used to determine the number of deferred stock units to be credited to the Reporting Person's account. F3 These securities consist of deferred stock units, held pursuant to the Deferred Fee Plan, and include deferred stock units acquired pursuant to the dividend reinvestment feature of such Plan. F4 No transaction is being reported on this line. Reported on a previously filed Form 4. F5 These securities consist of 902 restricted stock units ("RSUs") and 173 shares of common stock. Each RSU represents the Reporting Person's right to receive one share of common stock. References: F1, F2, F3 | A Award / grantCommon Stock · Non-derivative | 96.32A | 350.4 | IndirectDeferred Fee Plan | Form 4 ↗0001570836-26-000012 |
| 2026-07-06Filed 2026-07-08 | Williams ThomasDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents the number of deferred stock units acquired by the Reporting Person, in an exempt transaction, pursuant to the 2005 Director Deferred Fee Plan ("Deferred Fee Plan"). Each deferred stock unit is the economic equivalent of one share of common stock. The deferred stock units become payable solely in stock, generally following the Reporting Person's separation from service as a Director of the Company. F2 Represents the weighted average share price on the transaction date used to determine the number of deferred stock units to be credited to the Reporting Person's account. F3 These securities consist of deferred stock units, held pursuant to the Deferred Fee Plan, and include deferred stock units acquired pursuant to the dividend reinvestment feature of such Plan. F4 No transaction is being reported on this line. Reported on a previously filed Form 4. F5 These securities consist of 1,334 restricted stock units ("RSUs") and 1,037 shares of common stock. Each RSU represents the Reporting Person's right to receive one share of common stock. References: F1, F2, F3 | A Award / grantCommon Stock · Non-derivative | 96.32A | 350.4 | IndirectDeferred Fee Plan | Form 4 ↗0001320730-26-000010 |
| 2026-07-06Filed 2026-07-08 | THAMAN MICHAEL HDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents the number of deferred stock units acquired by the Reporting Person, in an exempt transaction, pursuant to the 2005 Director Deferred Fee Plan ("Deferred Fee Plan"). Each deferred stock unit is the economic equivalent of one share of common stock. The deferred stock units become payable solely in stock, generally following the Reporting Person's separation from service as a Director of the Company. F2 Represents the weighted average share price on the transaction date used to determine the number of deferred stock units to be credited to the Reporting Person's account. F3 These securities consist of deferred stock units, held pursuant to the Deferred Fee Plan, and include deferred stock units acquired pursuant to the dividend reinvestment feature of such Plan. F4 No transaction is being reported on this line. Reported on a previously filed Form 4. F5 These securities consist of 1,100 restricted stock units ("RSUs") and 7,011 shares of common stock. Each RSU represents the Reporting Person's right to receive one share of common stock. References: F1, F2, F3 | A Award / grantCommon Stock · Non-derivative | 96.32A | 350.4 | IndirectDeferred Fee Plan | Form 4 ↗0001228309-26-000010 |
| 2026-07-06Filed 2026-07-08 | ANDERSON KERRII BDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents the number of deferred stock units acquired by the Reporting Person, in an exempt transaction, pursuant to the 2005 Director Deferred Fee Plan ("Deferred Fee Plan"). Each deferred stock unit is the economic equivalent of one share of common stock. The deferred stock units become payable solely in stock, generally following the Reporting Person's separation from service as a Director of the Company. F2 Represents the weighted average share price on the transaction date used to determine the number of deferred stock units to be credited to the Reporting Person's account. F3 These securities consist of deferred stock units, held pursuant to the Deferred Fee Plan, and include deferred stock units acquired pursuant to the dividend reinvestment feature of such Plan. F4 No transaction is being reported on this line. Reported on a previously filed Form 4. F5 These securities consist of 1,100 restricted stock units ("RSUs") and 4,719 shares of common stock. Each RSU represents the Reporting Person's right to receive one share of common stock. References: F1, F2, F3 | A Award / grantCommon Stock · Non-derivative | 28.54A | 350.4 | IndirectDeferred Fee Plan | Form 4 ↗0001227159-26-000010 |
Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.